Pembrolizumab-Associated CD8+ Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma

Pembrolizumab-Associated CD8⁺ Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma

Neurol Neuroimmunol Neuroinflamm. 2021 Apr 6;8(4):e993. doi: 10.1212/NXI.0000000000000993. Print 2021 Jul.

¹ From the Department of Neurology (M.C.B., M.K., A.F., S.H.-F.); Department of Hematology and Oncology (M.J.); Department of Dermatology (L.F.); Department of Pathology (R.R.), Cantonal Hospital, St. Gallen; Department of Pathology (S.F.), University Hospital, Basel; and Department of Neurology and Department of Hematology and Oncology (T.H.), Cantonal Hospital St. Gallen, Switzerland.
² From the Department of Neurology (M.C.B., M.K., A.F., S.H.-F.); Department of Hematology and Oncology (M.J.); Department of Dermatology (L.F.); Department of Pathology (R.R.), Cantonal Hospital, St. Gallen; Department of Pathology (S.F.), University Hospital, Basel; and Department of Neurology and Department of Hematology and Oncology (T.H.), Cantonal Hospital St. Gallen, Switzerland. thomas.hundsberger@kssg.ch.

No abstract available